Senescence marker protein 30 has a cardio-protective role in doxorubicin-induced cardiac dysfunction

التفاصيل البيبلوغرافية
العنوان: Senescence marker protein 30 has a cardio-protective role in doxorubicin-induced cardiac dysfunction
المؤلفون: Shu-ichi Saitoh, Makiko Miyata, Yasuchika Takeishi, Tetsuro Shishido, Akihito Ishigami, Isao Kubota, Satoshi Suzuki, Tomofumi Misaka
المصدر: PLoS ONE, Vol 8, Iss 12, p e79093 (2013)
PLoS ONE
بيانات النشر: Public Library of Science (PLoS), 2013.
سنة النشر: 2013
مصطلحات موضوعية: Male, Aging, Anatomy and Physiology, Mouse, lcsh:Medicine, Apoptosis, Ascorbic Acid, medicine.disease_cause, Toxicology, Cardiovascular, Cardiovascular System, Diagnostic Radiology, Mice, Fibrosis, Molecular Cell Biology, polycyclic compounds, Myocytes, Cardiac, Phosphorylation, lcsh:Science, bcl-2-Associated X Protein, Cellular Stress Responses, Mice, Knockout, Multidisciplinary, biology, Cell Death, Caspase 3, Intracellular Signaling Peptides and Proteins, Animal Models, Up-Regulation, Proto-Oncogene Proteins c-bcl-2, Echocardiography, Medicine, Cardiomyopathies, Radiology, medicine.drug, Signal Transduction, Research Article, Senescence, medicine.medical_specialty, Cardiotonic Agents, Histology, Toxic Agents, Mice, Transgenic, macromolecular substances, Cardiovascular Pharmacology, Bcl-2-associated X protein, Model Organisms, Downregulation and upregulation, Internal medicine, medicine, Animals, Doxorubicin, Biology, Heart Failure, Myocardium, Calcium-Binding Proteins, lcsh:R, Stroke Volume, medicine.disease, Ascorbic acid, Mice, Inbred C57BL, carbohydrates (lipids), Oxidative Stress, Endocrinology, biology.protein, Cancer research, lcsh:Q, Reactive Oxygen Species, Oxidative stress, Biomarkers, DNA Damage
الوصف: BACKGROUND: Senescence marker protein 30 (SMP30), which was originally identified as an aging marker protein, is assumed to act as a novel anti-aging factor in the liver, lungs and brain. We hypothesized that SMP30 has cardio-protective function due to its anti-aging and anti-oxidant effects on doxorubicin (DOX)-induced cardiac dysfunction. METHODS AND RESULTS: SMP30 knockout (SMP30 KO) mice, SMP30 transgenic (SMP30 TG) mice with cardiac-specific overexpression of SMP30 gene and wild-type (WT) littermate mice at 12-14 weeks of age were given intra-peritoneal injection of DOX (20 mg/kg) or saline. Five days after DOX injection, echocardiography revealed that left ventricular ejection fraction was more severely reduced in the DOX-treated SMP30 KO mice than in the DOX-treated WT mice, but was preserved in the DOX-treated SMP30 TG mice. Generation of reactive oxygen species and oxidative DNA damage in the myocardium were greater in the DOX-treated SMP30 KO mice than in the DOX-treated WT mice, but much less in the SMP30 TG mice. The numbers of deoxynucleotidyltransferase-mediated dUTP nick end-labeling positive nuclei in the myocardium, apoptotic signaling pathways such as caspase-3 activity, Bax/Bcl-2 ratio and phosphorylation activity of c-Jun N-terminal kinase were increased in SMP30 KO mice and decreased in SMP30 TG mice compared with WT mice after DOX injection. CONCLUSIONS: SMP30 has a cardio-protective role by anti-oxidative and anti-apoptotic effects in DOX-induced cardiotoxicity, and can be a new therapeutic target to prevent DOX-induced heart failure.
اللغة: English
تدمد: 1932-6203
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::88da9fe40ab8d7ee6557abc29fd84d1aTest
http://europepmc.org/articles/PMC3876969?pdf=renderTest
حقوق: OPEN
رقم الانضمام: edsair.doi.dedup.....88da9fe40ab8d7ee6557abc29fd84d1a
قاعدة البيانات: OpenAIRE